Understanding the sources of errors in
Journal
Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630
Informations de publication
Date de publication:
01 Apr 2021
01 Apr 2021
Historique:
received:
30
12
2020
revised:
26
02
2021
accepted:
16
03
2021
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
18
5
2021
Statut:
epublish
Résumé
Overexpression of heat shock protein 90 (Hsp90) on the surface of breast cancer cells makes it an attractive molecular biomarker for breast cancer diagnosis. Before a ubiquitous diagnostic method can be established, an understanding of the systematic errors in Hsp90-based imaging is essential. In this study, we investigated three factors that may influence the sensitivity of
Identifiants
pubmed: 33996230
doi: 10.1364/BOE.418818
pii: 418818
pmc: PMC8086448
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2299-2311Subventions
Organisme : NIBIB NIH HHS
ID : R01 EB028148
Pays : United States
Informations de copyright
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.
Déclaration de conflit d'intérêts
Dr. Ramanujam has founded a company called Zenalux Biomedical and she and other team members have developed technologies related to this work where the investigators or Duke may benefit financially if this system is sold commercially.
Références
Cancer Res. 2018 Sep 1;78(17):5144-5154
pubmed: 29967260
Sci Rep. 2017 Oct 23;7(1):13772
pubmed: 29062013
Bioconjug Chem. 2011 Apr 20;22(4):777-84
pubmed: 21388195
Cancer Res. 2007 Apr 1;67(7):2932-7
pubmed: 17409397
PLoS One. 2017 Sep 29;12(9):e0185633
pubmed: 28961280
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):553-64
pubmed: 24521674
Nat Commun. 2019 Nov 6;10(1):5044
pubmed: 31695030
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):240-247
pubmed: 30708039
J Biomed Opt. 2018 Oct;23(10):1-9
pubmed: 30291698
Histopathology. 2016 Dec;69(6):1047-1054
pubmed: 27417415
Cell Stress Chaperones. 2008 Sep;13(3):357-64
pubmed: 18386162
PLoS One. 2015 Jan 30;10(1):e0117132
pubmed: 25635865
Cancer Lett. 2017 Feb 28;387:25-31
pubmed: 27195912
Breast J. 2009 Jan-Feb;15(1):34-40
pubmed: 19141132
Chem Biol. 2013 Sep 19;20(9):1187-97
pubmed: 24035283
Nat Rev Cancer. 2005 Oct;5(10):761-72
pubmed: 16175177
Sci Rep. 2019 Mar 5;9(1):3461
pubmed: 30837677
J Oral Maxillofac Pathol. 2011 May;15(2):161-7
pubmed: 22529574
Sci Rep. 2017 Dec 13;7(1):17487
pubmed: 29235516
Curr Protoc Cytom. 2012 Jul;Chapter 9:Unit 9.39
pubmed: 22752953
Pharmaceuticals (Basel). 2012 Sep 12;5(9):1008-20
pubmed: 24280702
J Biomed Opt. 2004 May-Jun;9(3):523-33
pubmed: 15189090
Trends Biotechnol. 2015 Nov;33(11):692-705
pubmed: 26463722
J Biomed Opt. 2018 Oct;23(10):1-19
pubmed: 30369108
Exp Dermatol. 2004 Jan;13(1):27-32
pubmed: 15009113
Biomed Res Int. 2016;2016:7343965
pubmed: 27595106
Proteomics Clin Appl. 2008 Jul 30;2(9):1223
pubmed: 20107526
Cancer Biol Ther. 2009 Oct;8(20):1952-61
pubmed: 19738418
Opt Express. 2007 Dec 10;15(25):16413-23
pubmed: 19550931
ACS Chem Biol. 2017 Apr 21;12(4):1047-1055
pubmed: 28103010
J Cancer Res Clin Oncol. 2016 Jul;142(7):1475-86
pubmed: 27106032
J Glob Oncol. 2015 Sep 23;1(1):3-6
pubmed: 28804765
Elife. 2018 Oct 17;7:
pubmed: 30328411
Breast Cancer (Auckl). 2018 Jan 08;12:1178223417752677
pubmed: 29434475
J Pharm Sci. 2017 Feb;106(2):639-644
pubmed: 27837968
JAMA. 2009 Oct 14;302(14):1551-6
pubmed: 19826024
Breast Cancer Res. 2012 Apr 17;14(2):R62
pubmed: 22510516
FEBS J. 2013 Mar;280(6):1381-96
pubmed: 23356585
J Biomed Opt. 2011 Jan-Feb;16(1):011012
pubmed: 21280899
Cancer Control. 2018 Jan-Mar;25(1):1073274817752332
pubmed: 29334791
J Cutan Pathol. 2018 Jul;45(7):498-503
pubmed: 29660167
World J Clin Oncol. 2014 Aug 10;5(3):509-19
pubmed: 25114864
Ann Surg Oncol. 2009 Oct;16(10):2717-30
pubmed: 19609829
BMC Cancer. 2010 Jul 05;10:353
pubmed: 20602789
Cancer Detect Prev. 2003;27(4):285-90
pubmed: 12893076
J Biomed Opt. 2011 Jul;16(7):076008
pubmed: 21806269
Theranostics. 2018 Oct 22;8(19):5336-5347
pubmed: 30555550
Nat Biomed Eng. 2017 Jul;1(7):
pubmed: 29750130
Adv Drug Deliv Rev. 2014 Feb;66:90-100
pubmed: 24064465
J Glob Oncol. 2015 Dec 23;2(1):4-8
pubmed: 28717676